Intended for healthcare professionals


NHS response to vaginal mesh scandal will be reviewed

BMJ 2018; 360 doi: (Published 22 February 2018) Cite this as: BMJ 2018;360:k887
  1. Jacqui Wise
  1. London

The government has announced a nine month review of how the NHS responded to public concerns over the safety of vaginal mesh implants, the pregnancy test Primodos, and the epilepsy drug sodium valproate.

Jeremy Hunt, England’s health and social care secretary, also announced £1.1m (€1.24m; $1.53m) to develop a prospective registry of all mesh procedures used for treating incontinence and prolapse in women—something the Royal College of Obstetricians and Gynaecologists has been calling for.1

NHS England estimates that more than 100 000 women have had surgery involving mesh and that 3-5% have had complications, but some recent studies have suggested that the true complication rate is much higher.

Speaking in the House of Commons, Hunt admitted that the official response to public health scandals caused by the side effects …

View Full Text

Log in

Log in through your institution


* For online subscription